What is the next earnings date for ENTO stock?
ENTERO THERAPEUTICS INC (ENTO) will report earnings on 2026-03-30, after the market close.
ENTERO THERAPEUTICS INC (ENTO) Forecast, Price Target & Analyst Ratings
NASDAQ:ENTO • US33749P5070
Current stock price
2.99 USD
+0.15 (+5.28%)
At close:
3.2 USD
+0.21 (+7.02%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENTERO THERAPEUTICS INC (ENTO).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $2.99 to mean target of N/A, Based on 6 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
43.33%
ENTO was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about ENTO.
In the previous month the buy percentage consensus was at a similar level.
ENTO was analyzed by 6 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Mar 30, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2025 - 2030
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A 178.96% | N/A 90.20% | ||||||
| EBITDA YoY % growth | N/A | N/A | N/A | N/A | N/A | -56.163M | N/A | -15.971M | -15.951M 0.12% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | N/A | N/A -31.90% | N/A -16.30% | -14.744M -13.83% | -26.433M -79.28% | -56.705M -114.52% | N/A | -16M | -16M | N/A -104.78% | N/A -31.58% | N/A -9.01% | N/A 145.67% | N/A 509.75% | N/A 114.40% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | -132,300.00 65.10% | -113,400.00 14.29% | -91,783.44 19.06% | -107,100.00 -16.69% | -90,009.23 15.96% | -10,942.20 87.84% | -266.25 97.57% | N/A 99.57% | N/A -34.51% | N/A -14.47% | N/A 5.17% | N/A 127.27% | N/A 391.11% | N/A 70.14% |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
-13.45%
EPS Next 5 Year
31.66%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
ENTERO THERAPEUTICS INC / ENTO Forecast FAQ
Can you provide the analyst count for ENTERO THERAPEUTICS INC stock?
The number of analysts covering ENTERO THERAPEUTICS INC (ENTO) is 6.